Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments
Go back to Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments| (NASDAQ: MNPR) | Delayed: 111.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $111.89 | 52 Week High | $ | |||
| Open | $111.89 | 52 Week Low | $ | |||
| Day High | $111.89 | P/E | N/A | |||
| Day Low | $111.89 | EPS | $ | |||
| Volume | 8,822 | |||||
